John J. Nolan

11.6k citations

115 papers · 7.6k indexed · 5 hit papers · h-index 41

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
Endocrine and Autonomic Systems top 0.5%
- Regulation of Appetite and Obesity

Papers in

Endocrinology, Diabetes and Metabolism 55
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Diabetes Treatment and Management 19
- Diabetes Management and Research 17
Physiology 30
- Adipose Tissue and Metabolism 15
- Diet and metabolism studies 13

Co-authors: Jerrold M. Olefsky Bernhard Ludvik Giovanni Pacini M. Joyce S. S. C. YEN Arlene J. Morales J C Nelson Andrea Mari
Journals: Diabetes Care (12 papers)Diabetes (10 papers)Diabetologia (7 papers)Diabetes Research and Clinical Practice (5 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)
Partner nations: Ireland United States Italy

In The Last Decade

John J. Nolan

110 papers receiving 7.4k citations

Hit Papers

5 papers align trajectories log scale

Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 2020 · 224 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Diabetes Care
2001 Diabetes Care
1996 Diabetes
1994 New England Journal of Medicine
1994 The Journal of Clinical Endocrinology & Metabolism

Peers

Countries citing papers authored by John J. Nolan

Since Specialization

Citations

This map shows the geographic impact of John J. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Nolan more than expected).

Fields of papers citing papers by John J. Nolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Nolan. The network helps show where John J. Nolan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John J. Nolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John J. Nolan Line = papers co-authored together John J. Nolan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms Diabetologia ·Martina Chiriacò, Domenico Tricò, John R. Petrie, Rafael Gabriel, Amalia Gastaldelli, John J. Nolan, Nebojša Lalić, Geltrude Mingrone, Andrea Mari, Andrea Natali	2025	0
2	Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies Metabolism ·Silvia Sabatini, John J. Nolan, Gráinne O’Donoghue, Aileen Kennedy, John R. Petrie, Mark Walker, Donal J. O’Gorman, Amalia Gastaldelli	2024	1
3	ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes Diabetes Care ·John J. Nolan, Anna R. Kahkoska, Zhila Semnani‐Azad, Marie‐France Hivert, Linong Ji, Viswanathan Mohan, Robert H. Eckel, Louis H. Philipson, Stephen S. Rich, Chandra Gruber, Paul W. Franks	2022	42
4	Metabolite Changes After Metabolic Surgery – Associations to Parameters Reflecting Glucose Homeostasis and Lipid Levels Frontiers in Endocrinology ·Sofie Ahlin, Consuelo Cefalo, Isabel Bondia‐Pons, Kajetan Trôst, Esmeralda Capristo, Luca Marini, Montserrat Romero, António Zorzano, Amalia Gastaldelli, Geltrude Mingrone, John J. Nolan	2021	4
5	Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum Diabetes Care ·Matthew C. Riddle, Louis H. Philipson, Stephen S. Rich, Annelie Carlsson, Paul W. Franks, Siri Atma W. Greeley, John J. Nolan, Ewan R. Pearson, Philip Zeitler, Andrew T. Hattersley	2020	54
6	Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care ·Wendy K. Chung, Karel Erion, José C. Florez, Andrew T. Hattersley, Marie‐France Hivert, Christine G. Lee, Mark I. McCarthy, John J. Nolan, Jill M. Norris, Ewan R. Pearson, Louis H. Philipson, Allison T. McElvaine, William T. Cefalu, Stephen S. Rich, Paul W. Franks Hit paper breakdown →	2020	224
7	Insulin sensitivity depends on the route of glucose administration Diabetologia ·Geltrude Mingrone, Simona Panunzi, Andrea De Gaetano, Sofie Ahlin, Valerio Spuntarelli, Isabel Bondia‐Pons, Chiara Barbieri, Esmeralda Capristo, Amalia Gastaldelli, John J. Nolan	2020	17
8	Study protocol for the Cities Changing Diabetes programme: a global mixed-methods approach BMJ Open ·A. David Napier, John J. Nolan, E K T Yi, Herausgeber Prof. Dr.-Ing. K. Zilch, Anna-Maria Volkmann	2017	11
9	Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism Scientific Reports ·María Isabel Hernández‐Álvarez, Angels Díaz‐Ramos, María Berdasco, Jeff E. Cobb, Evarist Planet, Азизов Олимжон Тохирович, Agnieszka Pazderska, 郭礼坤, 久英杉森, Antonio Gómez, Laura Rodríguez de la Ballina, Manel Esteller, Manuel Palacı́n, Donal J. O’Gorman, John J. Nolan, António Zorzano	2017	44
10	Gender-specific differences in carotid intima-media thickness and its progression over three years: A multicenter European study Nutrition Metabolism and Cardiovascular Diseases ·M. Kozàkovà, Carlo Palombo, C. Morizzo, John J. Nolan, Thomas R. Konrad, Joost Dekker, Beverley Balkau, Peter M. Nilsson	2011	25
11	Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population European Heart Journal ·M. Kozàkovà, Carlo Palombo, C. Morizzo, John J. Nolan, Thomas R. Konrad, Beverley Balkau, (unknown)	2010	57
12	Globalization, immigration and diabetes self-management: an empirical study amongst immigrants with type 2 diabetes mellitus in Ireland QJM ·Hood Thabit, Ai-Hui Ding, Michael Nash, Imad Brema, John J. Nolan, Gillian Martin	2009	21
13	In vivo and in vitro studies of GAD-antibody positive subjects with Type 2 diabetes: A distinct sub-phenotype Diabetes Research and Clinical Practice ·Donal J. O’Gorman, Obada Yousif, Gordon H. Dixon, Siobhán McQuaid, Elaine Murphy, Wathiq Mohammed Barrak Al Saadoun, D. Gasparro, Giovanni Pacini, Philip Newsholme, John J. Nolan	2008	3
14	Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus American Journal of Clinical Nutrition ·Fiona Moloney, O. Kyvlyuk, Anne Mullen, John J. Nolan, Helen M. Roche	2004	194
15	Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus Diabetic Medicine ·John J. Nolan, N. P. Jones, Rita Patwardhan, Dr.Shaila N.Shah	2000	99
16	Amylin Release During Oral Glucose Tolerance Test Diabetic Medicine ·Karl Thomaseth, Giovanni Pacini, Martin Clodi, Alexandra Kautzky‐Willer, John J. Nolan, Rudolf Prager, Jerrold M. Olefsky, Bernhard Ludvik	1997	19
17	Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms American Journal of Clinical Nutrition ·Nina Rizk, John J. Nolan	1995	98
18	Information technology factors in transferability of knowledge based systems in medicine Artificial Intelligence in Medicine ·Sk.Z. Hossian, Jan Talmon, John J. Nolan, P. McNair	1994	4
19	Factors influencing the transferability of medical decision support systems International Journal of Bio-Medical Computing ·John J. Nolan, P. McNair, Jytte Brender	1991	19
20	Essentials of Learning for Instruction Teachers College Record The Voice of Scholarship in Education ·John J. Nolan	1975	145

About John J. Nolan

John J. Nolan is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Endocrine and Autonomic Systems, Epidemiology and Surgery, having authored 115 papers that have together received 7.6k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Metabolism, Diabetes, and Cancer (23 papers), Diabetes Treatment and Management (19 papers), Diabetes Management and Research (17 papers), Pancreatic function and diabetes (16 papers), Adipose Tissue and Metabolism (15 papers), Diet and metabolism studies (13 papers) and Diabetes and associated disorders (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.1k citations), Endocrine and Autonomic Systems (859 citations), Physiology (2.2k citations), Behavioral Neuroscience (180 citations) and Epidemiology (1.6k citations). John J. Nolan has collaborated with scholars based in Ireland, United States and Italy. Frequent co-authors include Jerrold M. Olefsky, Bernhard Ludvik, Giovanni Pacini, M. Joyce, S. S. C. YEN, Arlene J. Morales, J C Nelson, Andrea Mari, Elaine Murphy and Robert R. Henry. Their work appears in journals such as Diabetes Care, Diabetes, Diabetologia, Diabetes Research and Clinical Practice and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact